Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Neurology

How quickly should PLEX start for an NMOSD attack?

At a Glance

For a severe NMOSD attack, plasma exchange (PLEX) should be evaluated and started as quickly as safely possible—often after or alongside high-dose intravenous steroids—because earlier treatment is linked with better recovery. MRI and antibody testing should not delay emergency care.

A neuromyelitis optica spectrum disorder (NMOSD) attack is a medical emergency. If you develop new or rapidly worsening symptoms—such as vision loss, severe weakness, numbness, trouble walking, or new bladder and bowel problems—do not wait. Contact your neurologist immediately or go to the nearest emergency department. Tell the emergency team that you have NMOSD and share the treatments you are currently taking.

Research shows that every day matters during an attack. For severe attacks, or if initial steroid treatments do not provide enough improvement, therapeutic plasma exchange (PLEX) should be started promptly to give you the best chance of recovery [1][2].

How PLEX Works and Why Timing Matters

During an attack, your immune system is actively causing inflammation in your optic nerves or spinal cord. PLEX (also called plasmapheresis) is a procedure that filters your blood to physically remove circulating antibodies and other inflammatory factors. However, PLEX cannot instantly undo tissue damage that has already occurred, which is why starting treatment early is critical to minimize long-term injury.

Studies observing NMOSD patients consistently show a link between earlier PLEX treatment and better outcomes:

  • Higher chances of improvement: In one retrospective study of 115 severe attacks, the likelihood of a complete return to the study’s definition of baseline was highest (around 50%) when PLEX was started on the day symptoms began, and dropped to 1-5% if delayed past 20 days [3].
  • Minimizing delays: Another large observational registry found that for every additional day between the start of the attack and the start of PLEX, the odds of complete remission decreased slightly (by about 6%) [4].
  • Better visual and physical outcomes: Meta-analyses show that earlier PLEX initiation is associated with a better response in reducing overall disability and preserving vision [5][6].

(Note: These numbers come from looking back at patient records. They show a strong trend that faster treatment is better, but they cannot predict your exact individual outcome. Factors like attack severity, location, and your baseline health also play major roles [4][3].)

Steroids First or PLEX First?

For most attacks, doctors will immediately start high-dose intravenous methylprednisolone (IVMP) (steroids given through an IV). During and shortly after the steroid course, your medical team will closely monitor your symptoms over several days. If there is no clear sign of improvement, medical consensus recommends adding PLEX as a “rescue” therapy promptly, rather than waiting weeks to see what happens [7][2].

However, in cases of very severe, function-threatening attacks (such as rapidly progressing paralysis or severe vision loss), experienced neurologists may recommend starting PLEX immediately alongside the steroids, rather than waiting to see if steroids fail [8][2].

What Does PLEX Involve?

PLEX is an intensive, hospital-based procedure that typically requires multiple sessions over a week or two. It involves placing a specialized IV catheter into a large vein. Because it is an invasive procedure, doctors must carefully weigh the benefits against potential risks. Common risks include drops in blood pressure, bleeding or infection at the catheter site, allergic reactions to replacement fluids, and low calcium levels (which can cause tingling). Not every attack requires PLEX, and your care team will help determine if the procedure is safe and appropriate for your specific situation. PLEX is used to treat acute attacks; it does not replace the long-term medications used to prevent future relapses.

Tests Should Not Delay Treatment

While tests like MRIs and blood draws for NMOSD antibodies are important for confirming the diagnosis, they should not delay emergency treatment. Ideally, blood samples for antibody testing should be drawn before you start PLEX, because the procedure physically removes antibodies from your blood, which could make your test results temporarily inaccurate. However, doctors can run these tests in parallel with your treatment [2].

Is it Ever Too Late for PLEX?

While early treatment is vastly superior, delayed PLEX is not useless. Research shows that some patients still experience meaningful improvements even when PLEX is started weeks after an attack begins [9]. However, because the risk of permanent disability increases over time, the goal should always be to evaluate the need for PLEX as swiftly as safely possible [4][10].

Common questions in this guide

How soon should PLEX be considered for an NMOSD attack?
A severe NMOSD attack should be evaluated for PLEX as quickly as safely possible because each day of delay can reduce the chance of full recovery. Doctors commonly add PLEX promptly when high-dose intravenous steroids do not produce clear improvement, and may start it alongside steroids for a very severe, function-threatening attack.
Are steroids given before plasma exchange for NMOSD?
For many attacks, clinicians begin high-dose intravenous methylprednisolone and watch closely for improvement over the next several days. If the attack is causing rapidly worsening paralysis or severe vision loss, PLEX may be started at the same time rather than waiting for steroids to fail.
Can plasma exchange still help if an NMOSD attack was treated late?
Yes, some people have meaningful improvement even when PLEX begins weeks after symptoms start. However, earlier treatment is associated with better recovery, and delay increases the risk of lasting disability, so PLEX should be assessed urgently.
Should MRI and antibody tests be completed before PLEX?
They should not delay emergency treatment. When possible, blood for NMOSD antibody testing is collected before PLEX because the procedure can remove antibodies and temporarily affect the result, while imaging and other tests can be done in parallel.
What should I expect if I need PLEX for an NMOSD attack?
PLEX is usually done in the hospital through a catheter placed in a large vein, with several sessions over about one to two weeks. Possible complications include low blood pressure, bleeding or infection, allergic reactions to replacement fluids, and low calcium that can cause tingling.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Neuromyelitis optica spectrum disorder.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific symptoms or lack of improvement would trigger you to add PLEX to my steroid treatment?
  2. 2.If my symptoms are very severe, would you consider starting PLEX at the same time as IV steroids?
  3. 3.What are the logistical steps and risks involved in getting a PLEX catheter placed at this hospital?
  4. 4.How can we ensure that necessary tests (like MRIs or antibody blood draws) are done in parallel so they do not delay emergency treatments?
  5. 5.If PLEX is needed, how many sessions are typically planned, and what complications should I watch out for during the process?

References

References (10)
  1. 1

    [Treatment of antibody-mediated encephalomyelitis : Strategies for the treatment of neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease].

    Ayzenberg I, Kleiter I

    Der Nervenarzt 2021; (92(4)):334-348 doi:10.1007/s00115-021-01090-4.

    PMID: 33783551
  2. 2

    Consensus Recommendations for the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorders (NMOSD): The MENACTRIMS Guidelines.

    Yamout B, Gouider R, Al-Roughani R, et al.

    CNS drugs 2026; (40(3)):283-303 doi:10.1007/s40263-025-01260-x.

    PMID: 41591715
  3. 3

    Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders.

    Bonnan M, Valentino R, Debeugny S, et al.

    Journal of neurology, neurosurgery, and psychiatry 2018; (89(4)):346-351 doi:10.1136/jnnp-2017-316286.

    PMID: 29030418
  4. 4

    Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions.

    Kleiter I, Gahlen A, Borisow N, et al.

    Neurology(R) neuroimmunology & neuroinflammation 2018; (5(6)):e504 doi:10.1212/NXI.0000000000000504.

    PMID: 30345331
  5. 5

    Efficacy of plasma exchange in acute attacks of neuromyelitis optica spectrum disorders: A systematic review and meta-analysis.

    Yu HH, Qin C, Zhang SQ, et al.

    Journal of neuroimmunology 2021; (350()):577449 doi:10.1016/j.jneuroim.2020.577449.

    PMID: 33227661
  6. 6

    Efficacy and Safety of Plasma Exchange and Immunoadsorption for Acute Optic Neuritis in Patients with Demyelinating Diseases: A Systematic Review and Meta-Analysis.

    Hanbazazh MA, Algethami MR, AnbarSerry AO, et al.

    Neurosciences (Riyadh, Saudi Arabia) 2026; (31(3)):220-229 doi:10.17712/1658-3183.2798.

    PMID: 42415978
  7. 7

    Beneficial effect of plasma exchange in acute attack of neuromyelitis optica spectrum disorders.

    Srisupa-Olan T, Siritho S, Kittisares K, et al.

    Multiple sclerosis and related disorders 2018; (20()):115-121 doi:10.1016/j.msard.2018.01.010.

    PMID: 29414283
  8. 8

    A pilot study comparing treatments for severe attacks of neuromyelitis optica spectrum disorders: Intravenous methylprednisolone (IVMP) with add-on plasma exchange (PLEX) versus simultaneous ivmp and PLEX.

    Songthammawat T, Srisupa-Olan T, Siritho S, et al.

    Multiple sclerosis and related disorders 2020; (38()):101506 doi:10.1016/j.msard.2019.101506.

    PMID: 31731214
  9. 9

    Therapeutic plasma exchange for neuromyelitis optica attacks: Evidence and challenges from a real-world cohort from Brazil.

    de Almeida GMR, de Araujo RS, Castrillo BB, et al.

    Journal of neuroimmunology 2024; (388()):578295 doi:10.1016/j.jneuroim.2024.578295.

    PMID: 38280268
  10. 10

    Risk factors associated with permanent disability in neuromyelitis optica spectrum disorders.

    Valdivia-Tangarife ER, Gamez-Nava JI, Cortés-Enríquez F, et al.

    Multiple sclerosis and related disorders 2022; (68()):104114 doi:10.1016/j.msard.2022.104114.

    PMID: 36037753

This page is for informational purposes only and does not constitute medical advice about NMOSD or PLEX. New or worsening symptoms require immediate contact with your neurologist or emergency medical care.